A GLP-1 RECEPTOR AGONIST WITH INSULIN PROVES EFFECTIVE

摘要

"A powerful and safer alternative to insulin" achieved robust glucose control for diabetes with no increased risk of hypoglycaemia or weight gain, conclude the authors of a systematic review of therapies published in The Lancet (online, 12 September 2014).